title: Intracavernosal injection therapy. Does it still have a role in erectile dysfunction?
abstract: BACKGROUND
  Male erectile dysfunction (ED) is a common problem in the community. It may go unnoticed unless specific questions are asked. The range of management options has increased markedly over the past two decades.
  
  
  OBJECTIVE
  This article revisits the option of intracavernosal injection therapy for male erectile dysfunction.
  
  
  CONCLUSIONS
  Erectile dysfunction has attracted considerable interest and research. The recent availability of an orally effective medication (sildenafil) has brought about a paradigm shift in its management.
authors.affiliation: Keogh Institute for Medical Research, Perth, Western Australia.
authors.forename: K K
authors.initials: KK
authors.lastname: Chew
mesh_terms: D000328:Adult; D000368:Aged; D000527:Alprostadil / Q000008:administration & dosage*; D001315:Australia; D007172:Erectile Dysfunction / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage*; D017060:Patient Satisfaction; D011379:Prognosis; D016896:Treatment Outcome
chemical_list: D010208:Papaverine; D000527:Alprostadil